Without looking it up, I can imagine the cognitive effects of Covid might be more severe for someone with ADHD. After looking it up, it seems there is some association between ADHD and worse outcomes: https://journals.sagepub.com/doi/full/10.1177/10870547211003....
It's also possible that ADHD makes it more difficult to scrupulously comply with self-quarantine measures, in which case it's a good public health decision to make Paxlovid available and reduce community spread. I'm not actually sure if Paxlovid reduces transmission though.
Thanks very much, that's the kind of medically appropriate implication I was looking for: "Conclusion: ADHD is associated with poorer outcomes in COVID-19 infection."
I'm sure that ADHD is comorbid with a variety of lifestyle and health problems that make COVID somewhat worse. But in general it does not directly affect health. Why not simply provide it to those with the comorbidities?
I consider community spread mostly a nonissue. We've known for many decades that if you can't get the replication rate below 1, the correlation between replication rate and how many get it is chaotic. We can't get the replication rate of COVID below 1, so there is little correlation between policies and outcomes. Obviously this does not apply if you are at risk or a caregiver of someone at risk. That's why saner countries than the USA (Germany is my favorite example) do not recommend vaccination against COVID for the general public.
It's also possible that ADHD makes it more difficult to scrupulously comply with self-quarantine measures, in which case it's a good public health decision to make Paxlovid available and reduce community spread. I'm not actually sure if Paxlovid reduces transmission though.